KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Current Assets (2016 - 2025)

Historic Current Assets for Travere Therapeutics (TVTX) over the last 17 years, with Q3 2025 value amounting to $371.1 million.

  • Travere Therapeutics' Current Assets rose 1427.91% to $371.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $371.1 million, marking a year-over-year increase of 1427.91%. This contributed to the annual value of $416.7 million for FY2024, which is 3243.86% down from last year.
  • According to the latest figures from Q3 2025, Travere Therapeutics' Current Assets is $371.1 million, which was up 1427.91% from $379.6 million recorded in Q2 2025.
  • Travere Therapeutics' 5-year Current Assets high stood at $686.2 million for Q3 2023, and its period low was $324.7 million during Q3 2024.
  • Moreover, its 5-year median value for Current Assets was $542.1 million (2023), whereas its average is $509.6 million.
  • Its Current Assets has fluctuated over the past 5 years, first surged by 4201.2% in 2021, then crashed by 5267.77% in 2024.
  • Quarter analysis of 5 years shows Travere Therapeutics' Current Assets stood at $582.8 million in 2021, then fell by 16.54% to $486.4 million in 2022, then grew by 26.79% to $616.8 million in 2023, then crashed by 32.44% to $416.7 million in 2024, then decreased by 10.94% to $371.1 million in 2025.
  • Its Current Assets was $371.1 million in Q3 2025, compared to $379.6 million in Q2 2025 and $374.2 million in Q1 2025.